Interview: Drug-Drug Interactions and Bleeding Risks with NOACs — Physician’s First Watch

Medical News |
October 11, 2017

Interview: Drug-Drug Interactions and Bleeding Risks with NOACs

By the Editors

Clinical Conversations interviews Dr. Shang-Hung Chang, author of a JAMA study examining the bleeding risks associated with taking direct-acting oral anticoagulants (known familiarly as NOACs or DOACs) along with other commonly prescribed medications that share some of the same metabolic pathways.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.